Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00035334
Status:
COMPLETED
Last Update Posted:
2006-02-14
First Post:
2002-05-02
Brief Title:
Study of the Safety and Efficacy of NC-503 in Secondary AA Amyloidosis
Sponsor:
Bellus Health Inc - a GSK company
Organization:
Bellus Health Inc - a GSK company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Gastrointestinal Diseases |
| Secondary AA Amyloidosis |
| Rheumatoid Arthritis |
| Nephrotic Syndrome |
| Familial Mediterranean Syndrome |
| Kidney Diseases |